The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this project is to examine the effects of varenicline treatment used
concomitantly with antipsychotic medications, on cognitive dysfunction in people with
schizophrenia. The secondary objective is to evaluate the effect of this combination therapy
on smoking in people with schizophrenia. This study will be a randomized, double blind,
parallel group, placebo controlled 8 weeks trial.